American Journal of Reproductive Immunology · 2020 · 30 citations · 42 references
Life SciencesCell BiologyMolecular BiologyGene ExpressionGene FunctionReproductive ImmunologyPlacental DevelopmentPlacental ImmunologyPregnancyPregnancy BiologyPregnancy ImmunologyTumor Suppressor GenesCytotrophoblast FunctionFetal-maternal InterfaceMaternal-fetal Interface DevelopmentMicroarray AnalysisMicroarray Differential Expression AnalysisPlacental Signaling PathwaysRecurrent Miscarriage Risk
PROBLEM: The dysregulation of trophoblast functions is one of the leading causes of recurrent miscarriage (RM), which frustrates 1%-5% of couples of childbearing ages. Sprouty 4 (SPRY4) is considered as a tumour suppressor and exerts a negative role in cell viability. However, its role in regulating trophoblast behaviors at the maternal-fetal interface remains largely unknown. METHOD OF STUDY: First-trimester villous samples were collected from RM patients and healthy controls (HCs) to determine the SPRY4 expression in human placenta during early pregnancy. The HTR8/SVneo cell line was introduced to clarify trophoblast cell functions via transfecting with specific short interfering RNA against SPRY4 or SPRY4-overexpressing lentivirus in vitro. In addition, gene expression microarray analysis was performed to explore the downstream molecules and pathways. RESULTS: Our results revealed that SPRY4 expression was significantly increased in the first-trimester cytotrophoblasts of RM patients compared with HCs. Furthermore, SPRY4 overexpression inhibited trophoblast proliferation and accelerated apoptosis in vitro, while SPRY4 knockdown reversed these effects. Mechanistically, IFN-γ -induced STAT1 expression and activation were involved in the regulation of trophoblast proliferation and apoptosis by SPRY4, and IFN-γ promoted SPRY4 expression and STAT1 phosphorylation through PI3K/AKT pathway. Additionally, both STAT1 and phosphorylated STAT (p-STAT) levels were also upregulated in trophoblasts from RM patients and positively correlated with SPRY4 expression. CONCLUSION: Our findings indicate that SPRY4 may act as a negative regulator of trophoblast functions through upregulating IFN-γ/PI3K/AKT-induced STAT1 activation. High levels of SPRY4 and STAT1 may contribute to RM development and progression, and blocking of either target could be a novel therapeutic strategy for RM patients.
42
The Practice Committee of the American Society for Reproductive Medicine
Alabama Birmingham · 2006 · 1.9K citations
Medicine, Gynecology, Obstetrics +14
Evaluation and treatment of recurrent pregnancy loss: a committee opinion
Fertility and Sterility · 2012 · 1.3K citations
Medicine, Gynecology, Obstetrics +13
Adrian Folkes, Khatereh Ahmadi, W. Alderton et al. · Journal of Medicinal Chemistry · 2008 · 746 citations · Full text